Why choose China for this procedure?

China offers advanced ophthalmic technology, including FDA-approved trifocal IOLs and state-of-the-art phacoemulsification platforms, at a significantly lower cost—approximately $4,500 per eye compared to $5,000–$7,000 in the U.S. or Europe. Chinese surgeons perform high volumes of cataract surgeries annually, often exceeding 500 cases per year, leading to exceptional technical proficiency. Many international hospitals in major cities like Beijing, Shanghai, and Guangzhou have English-speaking staff and JCI accreditation, ensuring quality care and streamlined logistics for medical travelers.